Routine drug monitoring of serum concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide do not predict clinical observations in cancer patients

The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

1993 • 14,121 citations

EORTC QLQ-C30 Scoring Manual

1995 • 2,372 citations

The use of the nitrogen mustards in the palliative treatment of carcinoma.With particular reference to bronchogenic carcinoma

1948 • 2,185 citations

Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases

1983 • 1,540 citations

When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function

1995 • 1,433 citations

Pain Measurement Tools and Methods in Clinical Research in Palliative Care

2002 • 418 citations

Response variability to analgesics: a role for non-specific activation of endogenous opioids

2001 • 417 citations

The Norwegian Brief Pain Inventory Questionnaire

2002 • 302 citations

Clinical Pharmacokinetics of Morphine

1991 • 280 citations

Opiate-induced Analgesia Is Increased and Prolonged in Mice Lacking P-glycoprotein

2000 • 270 citations

Understanding the experience of pain in terminally ill patients

2001 • 227 citations

The frequency and clinical course of cognitive impairment in patients with terminal cancer

1997 • 214 citations

Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat

1992 • 209 citations

What do cancer patients mean when they complain of concentration and memory problems?

1996 • 200 citations

Systematic review of factors affecting the ratios of morphine and its major metabolites

1998 • 167 citations

Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients

1995 • 148 citations

The metabolite morphine-6-glucuronide contributes to the analgesia produced by morphine infusion in patients with pain and normal renal function

1992 • 135 citations

Chronic nausea and morphine-6-glucuronide

1991 • 121 citations

Randomized placebo-controlled trial of the activity of the morphine glucuronides

2000 • 118 citations

Morphine, Morphine-3-Glucuronide, Morphine-6-Glucuronide, and 6-Monoacetylmorphine Determined by Means of Atmospheric Pressure Chemical Ionization-Mass Spectrometry-Liquid Chromatography in Body Fluids of Heroin Victims

1997 • 98 citations

Plasma morphine and glucuronide (M3G and M6G) concentrations in hospice inpatients

1997 • 98 citations

Is development of hyperalgesia, allodynia and myoclonus related to morphine metabolism during long‐term administration?: Six case histories

1998 • 94 citations

Start of oral morphine to cancer patients: effective serum morphine concentrations and contribution from morphine-6-glucuronide to the analgesia produced by morphine

2000 • 87 citations

Morphine-6-Glucuronide might Mediate the Prolonged Opioid Effect of Morphine in Acute Renal Failure

1990 • 78 citations

Concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide in serum and cerebrospinal fluid following morphine administration to patients with morphine-resistant pain

1994 • 73 citations

Morphine and morphine-6-glucuronide plasma concentrations and effect in cancer pain

1996 • 68 citations

Morphine and morphine metabolite concentrations in cerebrospinal fluid and plasma in cancer pain patients after slow-release oral morphine administration

1995 • 68 citations

Sample size: how many patients are necessary?

1995 • 63 citations

Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: A prospective survey in 300 adult cancer patients

2003 • 55 citations

Concentrations of morphine and morphine metabolites in CSF and plasma during continuous subcutaneous morphine administration in cancer pain patients

1996 • 51 citations

Plasma Concentrations and Renal Clearance of Morphine, Morphine-3-Glucuronide and Morphine-6-Glucuronide in Cancer Patients Receiving Morphine

1993 • 50 citations

Lack of morphi-ne-6-glucuronide antinociception after morphine treatment Is morphine-3-glucuronide involved?

1996 • 45 citations

Relationship between morphine analgesia and cortical extracellular fluid levels of morphine and its metabolites in the rat: a microdialysis study

1995 • 45 citations

The role of morphine glucuronides in cancer pain

1999 • 41 citations

Neuropsychological and Pharmacokinetic Assessment of Hospice Inpatients Receiving Morphine

1998 • 32 citations

Intravenous Titration with Morphine for Severe Cancer Pain: Report of 28 Cases

1999 • 31 citations

Clinical research in palliative care: Patient populations, symptoms, interventions and endpoints

2001 • 29 citations

Cerebrospinal Fluid and Plasma Concentrations of Morphine, Morphine-3-Glucuronide, and Morphine-6-Glucuronide in Patients Before and After Initiation of Intracerebroventricular Morphine for Cancer Pain Management

1999 • 25 citations

Cited By (0)

Loading...